The former Chairman of the Board since 2021, Jan Zetterberg, is a co-founder of Oxcia and was its CEO from 2014 to 2020.

Eva Sjökvist Saers

Eva Sjökvist Saers has worked on Oxcia’s Board of Directors since 2020 and has a long industrial life science background at senior level, including within Astra/AstraZeneca and as CEO of the pharmaceutical company APL. Eva Sjökvist Saers currently works on the boards of a number of companies, as chairman of Coegin Pharma AB and Dicot Pharma AB and as a board member of Alligator Bioscience AB, Apoex AB, Bluefish Pharmaceuticals AB and NextCell Pharma AB, as well as chairman of Swelife – a strategic innovation program. Eva is well versed in Oxcia’s business, has a deep understanding of the industry and a broad network.

“It is with great enthusiasm that I take over the baton from Jan,” says Eva Sjökvist Saers. I look forward to our continued joint work to significantly extend and improve the lives of patients affected by serious diseases such as cancer and inflammatory diseases.”